Laurence Jay Korn, PhD, Stanford University
Affiliations: | Protein Design Laboratories, Osseo, MN, United States |
Area:
http://www.walkersresearch.com/profilePages/Show_Executive_Title/Executiveprofile/L/Laurence_J_Korn_100005984.htmlWebsite:
http://www.forbes.com/finance/mktguideapps/personinfo/FromPersonIdPersonTearsheet.jhtml?passedPersonId=902906Google:
"Laurence Korn"Bio:
Laurence Jay Korn, Ph.D., co-founder of PDL Biopharma, was elected as one of the Company's first directors in July 1986. Since 2004, Dr. Korn has served as an independent consultant, and also serves on the Board of Directors of Symphogen A/S, a privately held entity. Dr. Korn served as our Chairperson of the Board between July 1986 and May 2002 and as our Chairman of the Board between May 2002 and June 2004. Dr. Korn also served as our Chief Executive Officer from January 1987 until April 2002. From March 1981 to December 1986, Dr. Korn headed a research laboratory and served on the faculty of the Department of Genetics at the Stanford University School of Medicine. Dr. Korn received his Ph.D. from Stanford University and was a Helen Hay Whitney Postdoctoral Fellow at the Carnegie Institution of Washington and a Staff Scientist at the MRC Laboratory of Molecular Biology in Cambridge, England, before becoming an Assistant Professor at Stanford.
http://www.prnewswire.com/news-releases/laurence-jay-korn-phd-relinquishes-role-as-chief-executive-officer-of-protein-design-labs-douglas-o-ebersole-to-serve-as-interim-chief-executive-officer-77232322.html
(Show less)
Mean distance: 106866 (cluster 28) | S | N | B | C | P |
Cross-listing: Chemistry Tree
Parents
Sign in to add mentorDavid Epel | research assistant | Stanford | |
John B. Gurdon | post-doc | Cambridge |
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Matsumoto Y, Korn LJ. (1988) Upstream sequences required for transcription of the TFIIIA gene in Xenopus oocytes. Nucleic Acids Research. 16: 3801-14 |
Tsurushita N, Ho L, Korn LJ. (1988) Nuclear factors in B lymphoma enhance splicing of mouse membrane-bound mu mRNA in Xenopus oocytes. Science (New York, N.Y.). 239: 494-7 |
Tsurushita N, Avdalovic NM, Korn LJ. (1987) Regulation of differential processing of mouse immunoglobulin mu heavy-chain mRNA. Nucleic Acids Research. 15: 4603-15 |
Tso JY, Van Den Berg DJ, Korn LJ. (1986) Structure of the gene for Xenopus transcription factor TFIIIA. Nucleic Acids Research. 14: 2187-200 |
Guinta DR, Tso JY, Narayanswami S, et al. (1986) Early replication and expression of oocyte-type 5S RNA genes in a Xenopus somatic cell line carrying a translocation. Proceedings of the National Academy of Sciences of the United States of America. 83: 5150-4 |
Guinta DR, Korn LJ. (1986) Differential order of replication of Xenopus laevis 5S RNA genes. Molecular and Cellular Biology. 6: 2536-42 |
Harper ME, Price J, Korn LJ. (1983) Chromosomal mapping of Xenopus 5S genes: somatic-type versus oocyte-type. Nucleic Acids Research. 11: 2313-23 |
Korn LJ. (1982) Transcription of Xenopus 5S ribosomal RNA genes. Nature. 295: 101-5 |
Korn LJ, Gurdon JB, Price J. (1982) Oocyte extracts reactivate developmentally inert Xenopus 5S genes in somatic nuclei. Nature. 300: 354-5 |
Gurdon JB, Dingwall C, Laskey RA, et al. (1982) Developmental inactivity of 5S RNA genes persists when chromosomes are cut between genes. Nature. 299: 652-3 |